Drug Type TCR therapy |
Synonyms HERV Targeted TCR-T (T-Cure Bioscience), 800 TCR, 800-TCR |
Target |
Mechanism ERVE-1 modulators(endogenous retrovirus group E member 1 modulators), Immunologic cytotoxicity, T lymphocyte replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Kidney Neoplasms | Phase 1 | US | 20 Jul 2018 |